The reduced presence of such cells along with a reduction in the frequency of tumor formation on the Ndst1f/f CD11cCre+ mutant background (Fig. 1) may point to a unique anti-tumor innate immunologic phenotype by Ndst1 deficient macrophages. This evidence concerns the gene NDST1 and neoplasm.